DXR Shariah Compliance
Screening Methodology: AAOIFI
DOUBTFUL
Last Updated: April 19, 2026
Report Source: 2025 Annual Report
Daxor Corp. Stock Analysis DXR
Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Read More Daxor Corp (DXR) Chart
Key Statistics of Daxor Corp (DXR)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$10.75Volume
2710.00P/E Ratio (TTM)
6.9152 Week Range
Market Cap
54.66MAvg. Volume
10.04KDividend Yield
-Financial Metrics & Statements of Daxor Corp (DXR)
FAQ's for Daxor Corp (DXR)
- According to Musaffa’s Shariah screening methodology, Daxor Corp (DXR) is currently classified as DOUBTFUL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.